Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy

• Published in: Archives of physiology and biochemistry 2008-12, Vol.114 (5), p.340-348
• Main Authors: Rodriguez, Walter E., Tyagi, Neetu, Deng, Alan Y., Adeagbo, Aso, Joshua, Irving G., Tyagi, Suresh C.
• Format: Article
• Language: English
• Subjects: Animals; Animals, Congenic; Biological and medical sciences; ECM remodelling; Electrocardiography; endothelial cardiomyocyte coupling; Endothelium - metabolism; Female; Fundamental and applied biological sciences. Psychology; Gene Expression Regulation; heart failure; Hypertension - diagnosis; Hypertension - diagnostic imaging; Hypertension - metabolism; Hypertension - pathology; Hypertrophy, Left Ventricular - diagnosis; Hypertrophy, Left Ventricular - diagnostic imaging; Hypertrophy, Left Ventricular - metabolism; Male; Metalloproteases - genetics; MMP; Myocytes, Cardiac - metabolism; Rats; Rats, Inbred Dahl; Rats, Inbred Lew; TIMP; Tissue Inhibitor of Metalloproteinases - genetics; Ultrasonography; Vertebrates: anatomy and physiology, studies on body, several organs or systems
• ISSN: 1381-3455; 1744-4160
• DOI: 10.1080/13813450802535978

Although congenic translocation of a segment from chromosome 10 from Lewis rat, containing an extracellular proteinase inhibitor gene, decreased blood pressure in Dahl-salt sensitive (DSS) rats, the relationship between the levels of matrix metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP), and cardiac function was unclear. In this study we investigated the cardiac effects of congenic translocation of a segment from chromosome 10 from Lewis rat, containing an extracellular proteinase inhibitor gene, in Dahl-salt sensitive rats. To test the hypothesis that left ventricular (LV) hypertrophy in DSS rats was due to high MMP and low TIMP levels and the decrease in blood pressure in congenic rats was associated with increase in proteinase inhibitor expression, cardiac function and levels of MMP and TIMP were determined in 16 weeks male DSS (D), Lewis (L) and congenic (CL-10) rats. Cardiac function was assessed by electrocardiography, echocardiography and a Millar catheter in LV cavity. LV MMP and TIMP levels were measured by Q-RT-PCR and Western blot analyses. In L, D and CL-10 rats, heart weight body weight (g g) were 3.73 ± 0.06, 4.45 ± 0.04 and 3.35 ± 0.05 × 10−3, respectively, suggesting significant (p < 0.05) LV hypertrophy (LVH) in D group. The ST duration was longer in D group compared with L group, suggesting coronary vasospasm, but normalized in CL-10 rats. The fractional shortening and ejection fraction were decreased in D group as compared with L group, but normalized in CL-10 groups. LV diameter was increased in D group as compared to L group, but normalized in CL-10 groups. The levels of MMP-9 were higher and TIMP were lower in D as compared to L groups, but normalized in CL-10 rats. Compared with control non-congenic Dahl rats, congenic rats exhibited lower blood pressure, amelioration of LV remodelling and dysfunction, as well as coronary abnormalities. In addition, congenic animals exhibited reduced myocardial expression of MMP-9, but increased expression of MMP-2 and TIMP-4 compared to non congenic animals. We concluded that the congenic transfer of TIMP ameliorated LV hypertrophy and cardiac dysfunction.